Liothyronine Sodium Roma Pharmaceuticals (Liothyronine Sodium)

The drug is a synthetic form of T3 that crosses cell membranes and binds to nuclear thyroid hormone receptors. This binding triggers transcription of specific genes that increase basal metabolic rate, enhance protein synthesis, and regulate cardiovascular and nervous system activity, thereby restoring the physiological actions of thyroid hormone.

Dosing of Liothyronine Sodium is individualized based on the patient’s age, weight, severity of thyroid deficiency, and response to therapy. The prescribing clinician determines the appropriate dose and titration schedule, often starting with a low dose and adjusting according to serial thyroid function test results.

The safety of Liothyronine Sodium in pregnancy and lactation has not been definitively established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and treatment decisions should be made in consultation with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

The primary alternative is levothyroxine (T4), a pro‑hormone that the body converts to T3. Liothyronine provides immediate T3 activity, leading to a faster onset of action, whereas levothyroxine offers a more stable, longer‑acting effect. Choice of therapy depends on clinical goals, patient tolerance, and specific endocrine conditions.

Liothyronine Sodium tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture, light, and humidity. Do not store in bathrooms or near heat sources, and ensure the container is tightly closed when not in use.

The medication is taken orally, usually with a glass of water. It may be taken on an empty stomach or as directed by the prescriber, and patients should follow the specific timing instructions provided to maintain consistent blood levels. Swallow tablets whole; do not crush or chew unless instructed otherwise.

Serious adverse events include cardiac arrhythmias such as atrial fibrillation, myocardial ischemia or angina, severe hypertension, and thyrotoxicosis leading to metabolic crisis. Patients with pre‑existing heart disease, uncontrolled hypertension, or osteoporosis should be monitored closely, and any signs of chest pain, palpitations, or severe headache warrant immediate medical attention.

Liothyronine Sodium is contraindicated in individuals with known hypersensitivity to the drug or any of its excipients, and in patients with untreated adrenal insufficiency. Caution is also advised for those with recent myocardial infarction, uncontrolled cardiac disease, or severe osteoporosis, as the drug may exacerbate these conditions.